CommercialAdministrativeLow impact
How Medical Policy at Regence works and why it matters for your health
Regence BlueCross BlueShield of Oregon·ID, OR, UT, WA·Provider News
We identified it
Feb 26, 2026
Summary
Regence published an informational policy document explaining their medical policy framework and review process for coverage determinations. This is educational content about how Regence evaluates treatments for medical necessity, clinical effectiveness, and peer-reviewed research support. The document highlights recent policy decisions including declining coverage for emerging liver cancer and herniated disc treatments (insufficient evidence) and approving coverage for Nutcracker syndrome treatment (based on provider feedback). No specific billing code changes, coverage denials, or effective dates are specified in this announcement.
Action Required
No immediate billing action required. This is educational material about Regence's medical policy development process. Billing teams should be aware that Regence continues to evaluate emerging treatments and may deny or approve coverage based on scientific evidence. Providers should document medical necessity thoroughly and submit feedback to Regence if they have concerns about specific coverage policies, as the policy notes provider input is considered during annual reviews.